These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Comparison of tBuBHQ with chemotactic peptide and phorbol ester in O2- production in HL-60 cells.
    Author: Tsukii K, Nakahata N, Watanabe K, Tsurufuji S, Ohizumi Y.
    Journal: Eur J Pharmacol; 1996 Feb 29; 298(1):87-95. PubMed ID: 8867924.
    Abstract:
    The effect of 2,5-di-(tert-butyl)-1,4-benzohydroquinone (tBuBHQ), a Ca2+ pump inhibitor, on superoxide anion (O2-) production was examined with a special reference to Ca2+ in HL-60 cells differentiated by dibutyryl cAMP, and compared with the effect of N-formyl-Met-Leu-Phe (fMLP) and phorbol 12-myristate 13-acetate (PMA). tBuBHQ caused O2- production and Ca2+ mobilization, but not phosphoinositide hydrolysis. fMLP caused O2- production, Ca2+ mobilization and phosphoinositide hydrolysis. PMA caused O2- production without affecting Ca2+ mobilization and phosphoinositide hydrolysis. EGTA and O,O'-bis(2-aminophenyl)ethyleneglycol- N,N,N',N'-tetraacetic acid, tetraacetoxymethyl ester (BAPTA/AM), an intracellular Ca2+ chelator, inhibited O2- production induced by fMLP, but not by tBuBHQ. Thapsigargin, another Ca2+ pump inhibitor, had a weak ability to produce O2-. fMLP, but not tBuBHQ, caused BAPTA/AM-sensitive activation of phospholipase A2 and D. tBuBHQ caused O2- production by interacting with phosphatidylcholine in a cell-free system. The results suggest that tBuBHQ causes O2- production independent of Ca2+, and Ca2+ might be a cofactor in the activation of phospholipase A2 and D upstream in fMLP-induced O2- production.
    [Abstract] [Full Text] [Related] [New Search]